MENS logo

Jyong Biotech Ltd. (MENS)

Profile

Full Name

Jyong Biotech Ltd.

Ticker

NASDAQ: MENS

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Taiwan

IPO

June 17, 2025

Indexes

Not included

Website

http://jyongbio.com

Employees

31

Key Details

Price

$17.96(+14.61%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$0.04(+31.43% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $17.96
    MENS price is $17.96

    30-Day Relative Volume

    0.41
    MENS 30-day relative volume is 0.41

    Price Performance

    Price Most recent change

    +14.61%
    MENS price was up +14.61% on Jul 30, 2025

    Price YTD change

    -
    MENS price ytd change is unknown

    Price 1-year change

    -
    MENS price 1-year change is unknown

    Price 3-year change

    -
    MENS price 3-year change is unknown

    Price Range

    Price All-time high

    $19.99
    MENS price is currently -10.16% below its historical high of $19.99

    Price 3-year low

    $6.01
    MENS price is currently +198.84% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $1.37B
    MENS market capitalization is $1.37 billion

    Market cap 3-year change

    -
    MENS market capitalization 3-year change is unknown

    Market cap All-time high

    $1.37B
    MENS market capitalization is currently at an all-time high

    Market cap sector rank

    77.82%
    MENS market capitalization is higher than 77.82% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -
    MENS shares outstanding 1-year change is unknown

    Shares Outstanding 3-Year Change

    -
    MENS shares outstanding 3-year change is unknown

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.13
    MENS beta is 1.13

    200-day SMA

    $10.33
    MENS price is currently +73.92% above its 200-day simple moving average

    50-day SMA

    $10.33
    MENS price is currently +73.92% above its 50-day simple moving average

    RSI

    80.05
    MENS 14-day relative strength index is 80.05

    Volume

    0.41
    MENS 30-day relative volume is 0.41

    ATR

    $2.38
    MENS average true range is $2.38

    10-day Historical Volatility

    137.43%
    MENS 10-day historical volatility is 137.43%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    -
    MENS annual revenue value is unknown

    Revenue Analysts estimate

    -
    MENS annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -
    MENS annual revenue 1-year change is unknown

    Revenue Sector rank

    -
    MENS annual revenue is unknown

    EPS

    EPS

    -$0.04
    MENS annual earnings per share is -$0.04

    EPS Analysts estimate

    -
    MENS annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +31.43%
    MENS annual earnings per share is up +31.43% year-on-year

    EPS Sector rank

    80.38%
    MENS annual earnings per share is higher than 80.38% of companies in Healthcare sector

    Profit

    Gross profit

    -
    MENS annual gross profit value is unknown

    Gross margin

    -
    MENS annual gross profit margin value is unknown

    Operating profit

    -$2.06M
    MENS annual operating income is -$2.06 million

    Operating margin

    -
    MENS annual operating profit margin value is unknown

    Net income

    -$3.02M
    MENS annual net profit is -$3.02 million

    Net margin

    -
    MENS annual net profit margin value is unknown

    Expenses

    Total expenses

    $2.06M
    MENS annual total expenses is $2.06 million

    Operating expenses

    $2.06M
    MENS annual total operating expenses is $2.06 million

    Cost of goods sold

    -
    MENS annual cost of goods sold value is unknown

    Selling, general & administrative expenses

    $1.13M
    MENS annual SGA is $1.13 million

    Depreciation and amortization

    $120.00K
    MENS annual depreciation & amortization is $120.00 thousand

    Interest expense

    $1.03M
    MENS annual interest expense is $1.03 million

    Income tax

    $0.00
    MENS annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$1.98M
    MENS annual earnings before interest & taxes is -$1.98 million

    EBITDA

    -$1.86M
    MENS annual EBITDA is -$1.86 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $6.37M
    MENS annual total assets is $6.37 million

    Non current assets

    $6.16M
    MENS annual long term assets is $6.16 million

    Current assets

    $206.00K
    MENS annual total current assets is $206.00 thousand

    Cash and cash equivalents

    $98.00K
    MENS annual cash & cash equivalents is $98.00 thousand

    Accounts receivable

    -
    MENS annual accounts receivable value is unknown

    Inventory

    -
    MENS annual inventory value is unknown

    Liabilities

    Total liabilities

    $42.88M
    MENS annual total liabilities is $42.88 million

    Long term liabilities

    $30.76M
    MENS annual total long term liabilities is $30.76 million

    Current liabilities

    $12.13M
    MENS annual total current liabilities is $12.13 million

    Accounts payable

    $3000.00
    MENS annual accounts payable is $3000.00

    Debt

    Total debt

    $18.14M
    MENS annual total debt is $18.14 million

    Total debt 1-year change

    +8.65%
    MENS annual total debt is up +8.65% year-on-year

    Long term debt

    $10.69M
    MENS annual long term debt is $10.69 million

    Short term debt

    $7.44M
    MENS annual short term debt is $7.44 million

    Equity & Capital

    Shareholders equity

    -$36.52M
    MENS annual stockholders equity is -$36.52 million

    Book value

    -$36.52M
    MENS annual book value is -$36.52 million

    Retained earnings

    -$33.08M
    MENS annual retained earnings is -$33.08 million

    Working capital

    -$11.92M
    MENS annual working capital is -$11.92 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$3.62M
    MENS annual cash flow from operations is -$3.62 million

    Cash from operations 1-year change

    -39.33%
    MENS annual cash flow from operations is down -39.33% year-on-year

    Cash from investing

    $0.00
    MENS annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    -100%
    MENS annual cash flow from investing activities is down -100% year-on-year

    Cash from financing

    $1.99M
    MENS annual cash flow from financing activities is $1.99 million

    Cash from financing 1-year change

    -1.87%
    MENS annual cash flow from financing activities is down -1.87% year-on-year

    CAPEX

    CAPEX

    -
    MENS annual capital expenditures value is unknown

    CAPEX 1-year change

    -
    MENS annual capital expenditures 1-year change is unknown

    Free Cash Flow

    Free cash flow

    -$3.62M
    MENS annual free cash flow is -$3.62 million

    Free cash flow 1-year change

    -39.33%
    MENS annual free cash flow is down -39.33% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    MENS annual gross profit margin value is unknown

    Operating margin

    -
    MENS annual operating profit margin value is unknown

    Net margin

    -
    MENS annual net profit margin value is unknown

    ROA & ROE

    ROA

    -47.42%
    MENS annual return on assets is -47.42%

    ROE

    8.27%
    MENS annual return on equity is 8.27%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    MENS price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    MENS price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -37.39
    MENS price to book ratio is -37.39

    PB ratio Sector rank

    1.24%
    MENS price to book ratio is higher than 1.24% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    MENS price to sales ratio value is unknown

    PS ratio Sector rank

    -
    MENS price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $1.38B
    MENS enterprise value is $1.38 billion

    Enterprise value Sector rank

    76.96%
    MENS enterprise value is higher than 76.96% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -
    MENS EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    MENS EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.02
    MENS annual current ratio is 0.02

    Quick ratio

    -
    MENS annual quick ratio value is unknown

    Leverage

    Debt to equity

    -0.50
    MENS annual debt to equity ratio is -0.50

    Interest coverage ratio

    -1.92
    MENS annual interest coverage ratio is -1.92

    Risk & Stability

    Piotroski F-Score

    -
    MENS piotroski f-score value is unknown

    Altman Z-Score

    -
    MENS altman z-score value is unknown

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with MENS included

    Stocks with high beta
    Best performing stocks last month
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Stocks with high RSI
    Biggest stock gainers today
    Biotech Companies
    Ex Dividend dates calendar
    • What is the ticker symbol for Jyong Biotech Ltd.?
    • Does Jyong Biotech Ltd. pay dividends?
    • What sector is Jyong Biotech Ltd. in?
    • What industry is Jyong Biotech Ltd. in?
    • What country is Jyong Biotech Ltd. based in?
    • When did Jyong Biotech Ltd. go public?
    • Is Jyong Biotech Ltd. in the S&P 500?
    • Is Jyong Biotech Ltd. in the NASDAQ 100?
    • Is Jyong Biotech Ltd. in the Dow Jones?
    • When does Jyong Biotech Ltd. report earnings?

    What is the ticker symbol for Jyong Biotech Ltd.?

    The ticker symbol for Jyong Biotech Ltd. is NASDAQ:MENS

    Does Jyong Biotech Ltd. pay dividends?

    No, Jyong Biotech Ltd. does not pay dividends

    What sector is Jyong Biotech Ltd. in?

    Jyong Biotech Ltd. is in the Healthcare sector

    What industry is Jyong Biotech Ltd. in?

    Jyong Biotech Ltd. is in the Biotechnology industry

    What country is Jyong Biotech Ltd. based in?

    Jyong Biotech Ltd. is headquartered in Taiwan

    When did Jyong Biotech Ltd. go public?

    Jyong Biotech Ltd.'s initial public offering (IPO) was on June 17, 2025

    Is Jyong Biotech Ltd. in the S&P 500?

    No, Jyong Biotech Ltd. is not included in the S&P 500 index

    Is Jyong Biotech Ltd. in the NASDAQ 100?

    No, Jyong Biotech Ltd. is not included in the NASDAQ 100 index

    Is Jyong Biotech Ltd. in the Dow Jones?

    No, Jyong Biotech Ltd. is not included in the Dow Jones index

    When does Jyong Biotech Ltd. report earnings?

    The date for Jyong Biotech Ltd.'s next earnings report has not been announced yet
    On this page